Events

Antibody-Drug Conjugates (ADCs) have emerged as a major focus in cancer therapy in recent years due to their high targeting precision and superior therapeutic efficacy. According to market forecasts, the global ADC market is expected to grow rapidly at a compound annual growth rate (CAGR) of 29.57% from 2025 to 2030, indicating a strong development potential. However, the development of ADC drugs is highly complex and challenging, requiring specialized knowledge and rigorous technical support throughout the entire process—from preclinical studies and clinical trials to process development and commercialization.

This seminar features two distinguished speakers: Dr. Wan-Fen Lee, Director of Product Development at TaiGen Biotech, and Dr. Timeus Kao, Associate General Manager of R&D at Formosa Laboratories. Both experts bring extensive hands-on experience and deep insights into the ADC development process.

This is a rare opportunity for professionals and academic researchers interested in biotech and ADC drug development to broaden their perspectives and engage in valuable knowledge exchange.

Date & Time: Friday, May 23, 2025, 9:30–12:00 (Registration starts at 9:00)
Venue: Room E108, 1F, Building E, National Biotechnology Research Park (No. 107, Lane 130, Section 1, Academia Rd., Nangang Dist., Taipei)
Target Audience: Companies, researchers, and students interested in ADC drug development
Registration Link:https://forms.gle/ojTiqhvkWXcGqww76

Course Schedule：

Time	Topic	Speaker
1hr	ADC Drug Development: From Preclinical Research to Human Trials Target Selection & ADC Design Preclinical Toxicology Studies IND Application Human Clinical Trials	Dr. Wan-Fen Lee Director, Product Development OBI Pharma
1.5hr	CMC of ADCs with Emphasis on Supply Chain Management Challenges in Development and Importance of CMC Chemistry of ADCs Key Points of Quality Control Regulatory Considerations Supply Chain Strategies	Dr. Timeus Kao Formosa Laboratories Associate GM, R&D

Speaker Profiles
Dr. Wan-Fen Lee
Director of Product Development, TaiGen Biotech

Ph.D. in Toxicology, University of Washington, Seattle
Former Assistant Professor, University of Washington; Associate Researcher, NHRI
Dr. Timeus Kao
Associate General Manager, R&D, Formosa Laboratories

Chemistry, Tsing-Hua University
Expertise: Organic synthesis and photochemistry

■ Course Fee
Regular Price: NT$3,500
Early Bird: NT$1,800 (until May 18)
Full-Day Bundle (both sessions on 5/23, includes lunch): NT$3,500

■ Payment Details
Account Name: Development Center for Biotechnology
Bank: Bank SinoPac, Zhongxiao Branch
Bank Code: 807
Account No.: 005-004-0001772-3
※ Please make payment only after receiving confirmation. Provide the last 5 digits after remittance for verification.

■ Important Notes
The academy reserves the right to adjust the course content, speakers, and venue as needed. Any unspecified matters may be supplemented, clarified, or amended accordingly.
If you require a certificate of course hours, please contact us via email after the event.
Contact Person: Ms. Lin, Academic Affairs Manager
Phone: (02)7700-3800 Ext. 5283
Email: rebecca206tw@dcb.org.tw
In the event of force majeure (e.g., natural disaster) causing closure of the event venue, the course will be postponed, and participants will be notified of the new schedule.
If you are unable to attend the rescheduled course, a full refund will be provided. To request a refund, you must provide a copy of your bankbook. Failure to do so will result in the inability to process the refund.